web stats
Member Login
Lost your password?
Not a member yet? Sign Up!

Nice ideas post by Manual of Ideas

July 12, 2011
By

Whopper is a deep value investor. His blog is http://www.whopperinvestments.com

I normally am not a big fan of the “quick ideas” articles, but this write up by the Manual of Ideas has some nice ideas in it.

One of them, AEY, is a stock I am currently very long and have written up several times before. Another, SMID, is a stock I have invested in before. I don’t have a position in it currently, but I have kept my eye on it. It currently trades well below its tangible book value (almost $2.40 a share) and is approaching its net current asset value ($1.36 per share). If it gets a bit lower, I would likely get very long. I’d also open up a position if some of the positions in my portfolio hit my buy targets and free up some cash.

As for the other stocks, I could certainly see some value in BAMM, but I couldn’t see myself going long the stock unless management announces some serious changes…. They’d basically need to announce they were going to treat their stores like complete cash cows, stop any and all reinvestment but the most critical for maintaining operations, and begin massive share repurchases.

ABL looks real interesting. With all three divisions profitable, I could see an investor having “multiple lines of defense” in the name. Asset value, sum of the parts / break up value, earnings protection, etc. I haven’t done any research, but it will warrant a look.

MPAC and OCCF both look interesting as well, though I think they’re both outside my circle of competence. I have two stocks I’m currently doing some deeper research into and trying to establish a position in (and then hopefully do a write up!), but these two are getting added to my watchlist. They do look interesting, so maybe you should beat me to it and do the same!!!!

Disclosure: Long AEY and could establish a position in SMID at any time

 

Disclaimer

The content contained in this blog represents only the opinions of its author(s). We, or clients we advise, may hold long or short positions in securities mentioned in the blog. In no way should anything on this website be considered investment advice and should never be relied on in making an investment decision. Read that last line again. Also, this blog is not a solicitation of business. The content herein is intended solely for the entertainment of the reader and the author(s).

Now that I’ve begun to be syndicated on several sites, please post comments on my site,whopperinvestments.com – it’s the only way for me to know who’s commenting and gives the best odds of me responding.

Check out our Premium section. 14 day trial is only $1!

Sign Up Today

You aren’t subscribed?

If you enjoyed this post, you can subscribe for our free content via RSS Feed, Facebook, Twitter You can unsubscribe at any time, and your information will not be sold to any third parties.

Related posts:

  1. Sponsored Post: Keryx Biopharma (NASDAQ:KERX) Product Development Update
  2. SPONSORED POST: An Interesting Biotech Stock: ImmunoCellular
  3. Guest Post: Christopher Risso-Gill on Peter Cundill’s Last Major Investment Call

Tags: aey, micro cap stocks, small cap stocks, Value Stocks

Leave Comments Below: